Is the intrinsic sympathomimetic activity (ISA) of beta-blocking compounds relevant in acute myocardial infarction? B. SilkeS. P. VermaS. H. Taylor Originals Pages: 509 - 515
Influence of cardioselectivity and respiratory disease on pulmonary responsiveness to beta-blockade H. W. ClagueD. AhmadS. G. Carruthers Originals Pages: 517 - 523
Changes in left ventricular mass during a double-blind study with chlorthalidone and slow-release nifedipine L. A. FerraraG. de SimoneG. Vallone Originals Pages: 525 - 528
Double-blind comparison of once-daily bopindolol, pindolol and atenolol in essential hypertension W. SchiessD. WelzelR. Gugler Originals Pages: 529 - 534
Effect on heart rate over 24 hours of pindolol administered for 14 days J. P. KantelipJ. F. TroleseP. Duchêne-Marullaz Originals Pages: 535 - 538
Dose-response relationship in normal subjects of prenalterol, a beta-adrenergic agonist with positive inotropic and resistance lowering effects S. RasmussenP. -F. Høilund-CarlsenJ. Giese Originals Pages: 539 - 543
Simple and reliable radioreceptor assay for beta-adrenoceptor antagonists and active metabolites in native human plasma A. WellsteinD. PalmE. Mutschler Originals Pages: 545 - 553
Hydralazine-induced lupus: is there a toxic metabolic pathway? J. A. TimbrellV. FacchiniR. Mansilla-Tinoco Originals Pages: 555 - 559
Studies on the possible central effects in man of a neuropeptide (ACTH 4–9 analogue) A. N. NicholsonB. M. StoneS. J. Jones Originals Pages: 561 - 565
Physical exercise and binding of digoxin to skeletal muscle — Effect of muscle activation frequency T. JoretegT. Jogestrand Originals Pages: 567 - 570
Quinidine-induced changes in serum and skeletal muscle digoxin concentration; evidence of saturable binding of digoxin to skeletal muscle T. JogestrandK. Schenck-GustafssonR. Dahlqvist Originals Pages: 571 - 575
Pharmacokinetics and pharmacodynamics of a novel orally active angiotensin converting enzyme inhibitor (HOE 498) in healthy subjects P. U. WitteR. IrmischH. Metzger Originals Pages: 577 - 581
Pharmacokinetics of propranolol during pregnancy M. F. O'HareC. D. KinneyD. G. McDevitt Originals Pages: 583 - 587
Pharmacokinetics of high doses of piretanide in moderate to severe renal failure C. MaroneF. C. ReubiW. Lahn Originals Pages: 589 - 593
Implications of intraindividual variability in bioavailability studies of furosemide A. GrahnénM. HammarlundT. Lundqvist Originals Pages: 595 - 602
Use of single doses and rapid sampling to detect interactions with cimetidine H. GhabrialP. J. HarmanK. J. Breen Originals Pages: 603 - 606
Pharmacokinetics of methotrexate in erythrocytes in psoriasis J. HendelA. Nyfors Originals Pages: 607 - 610
Presence of chlorprothixene and its metabolites in breast milk I. MathesonA. EvangG. Syversen Short Communication Pages: 611 - 613
Pharmacokinetics of the oral narcotic analgesic bezitramide and preliminary observations on its effect on experimentally induced pain D. K. F. MeijerG. HovingaH. Wesseling Short Communication Pages: 615 - 618
Biperiden effects and plasma levels in volunteers M. HollmannE. BrodeN. Wetzelsberger Short Communication Pages: 619 - 621
Cimetidine bioavailability and variable renal clearance A. Grahnén Letter To The Editor Pages: 623 - 624